Brief · Use case · Public Affairs
Pricing Rule Change Scan.
LiveScanTake stock of what changed in one country's pricing and reimbursement rules in six months, who moved each change and what this scan does not cover.
Pricing Rule Change Scan is a ready-made use case for Public Affairs. It ships under the Scan template.
For public affairs and market access leads who need a sourced inventory before a meeting. You get the boundary stated first, every change found with its category and maturity, how the field divides and what was not looked at. Items are cited or marked as gaps.
Add it to your library to reuse from New → From template. Edit the saved copy in your library on the service form.
The decision
What changed in one country’s pricing and reimbursement rules over the last six months for a specialty product class, and who moved it?
What is scanned
A rule change leaves a trail in several places. The scan names the country and the product class first, then searches each place and says which ones it could not open.
| Source | What it holds | What the scan does with it |
|---|---|---|
| Official publications | The country’s ministry notices, legal gazette and agency announcements: what changed and when it took effect. | Lists each change as one row with its category, maturity and date. |
| HTA body publications | Methods updates, procedural changes and decisions that alter how a product is assessed or priced.2 | Lists them as separate rows, with the body named. |
| Industry and patient group statements | Consultation responses and public positions that show who pushed for or against a change. | Lists them as signals with their maturity and does not treat them as decisions. |
| EU-level rules | The EU time limits on national price and reimbursement decisions, and the phase-in of joint clinical assessments.1,2 | Notes where an EU rule bounds a national change. |
What the scan does
The boundary is the first finding. The scan names the country, the product class and the six-month window, and says what counts as a rule change and what does not. A borderline item, such as a draft proposal, is listed as borderline and not dropped.1
EU rules set the frame. Under Council Directive 89/105/EEC, national authorities must decide on a price within 90 days of a complete application and on inclusion in health insurance within a further 90 days, or 180 days when the two are handled together. The scan notes any change that touches those limits, and any change from the EU HTA Regulation, whose joint clinical assessments began on 12 January 2025.1,2
Who moved it. Each change names the body that made it, and a position from an association or a patient group is recorded as a position and not as a decision.
What the scan does not cover. Unpublished drafts, private negotiations and anything behind a login are listed as not covered.
Recommended length
Standard
A six-month window in one country gives a short list. Standard carries the boundary, the items, how the field divides and what was not covered in about 1,300 words.
You can pick another length on the form. The other two stay available.
Assumptions the scan checks
The scan states the assumptions its boundary and its sources rest on, and the closing section says what they leave out. Examples for this subject:
- The country’s official publications are searchable in a language the scan can read.
- A rule change is dated by its publication or its effective date, and the scan says which.
- The product class is the one the rules apply to.
Standards, guidance and sources
EU rules that bound national changes
The decision practice behind the memo itself is on the template page.
What gets flagged
Any change that rests on a secondary report and not an official publication, any draft listed as borderline, and any source the scan could not open.
What arrives
- Scope and boundary
- How the scan was run
- What is out there
- How the field divides
- What stands out
- What this does not cover
What it will not do
It does not rank or score the items it finds, and it does not recommend one. A scan lists what exists; when you need a view on it, run a Comparison or a Decision Memo on the items you choose.
It does not interpret what a change means for your product. That is for an Overview or a Decision Memo.
It does not rank or score the items. A scan says what exists; it does not say which item is preferable.
It is a snapshot of one date. It does not monitor the field after that date.
It lists what it could find in the sources it names. Items in sources it could not open are listed as not covered.
References
- [1] Council of the European Communities. Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems. Check the national rules that implement it.
- [2] European Parliament and Council. Regulation (EU) 2021/2282 on health technology assessment. Application dates for medicinal products: 12 January 2025, 13 January 2028 and 13 January 2030. The phase-in dates are as given in the European Commission’s factsheet and EUR-Lex summaries; the regulation’s text was not read in full for this page.
Links checked 9 October 2026
These are the sources the template drew on. None of their authors or issuers has reviewed it.
About the Brief service
A Brief is a written answer from one specialist, at the depth you asked for. It arrives with its sources, and it closes by saying plainly what would change the conclusion. Nothing is hidden behind a summary, and anything the expert could not source is marked as a gap rather than filled in.
To edit a saved template, open New → Brief → From template, or the library rail on the service form.